Abstract
Natural product inspired scaffolds remain a valuable source of novel anticancer agents. In this study, a series of verbenone-selenophene derivatives (2A-2U) were rationally designed and synthesized. Their antiproliferative activities were evaluated in vitro against human cancer cells, with A549 non-small cell lung cancer cells as the primary model and LO2 normal hepatic cells as a reference for toxicity. Structure-activity relationship analysis revealed that both the electronic nature and positional pattern of aryl substituents strongly influenced potency: ortho-substituted derivatives and para-bromo substitution conferred the greatest activity, identifying compound 2R (4-Br) as the most promising hit (IC(50) ≈ 9 μM in A549 cells) with relatively low toxicity toward LO2 cells. Mechanistic studies demonstrated that 2R significantly inhibited A549 cell proliferation by inducing a marked, concentration-dependent G0/G1 cell-cycle arrest and promoting apoptotic cell death. Furthermore, 2R caused a pronounced loss of mitochondrial membrane potential (ΔΨ (m)) and triggered a concentration-dependent accumulation of intracellular reactive oxygen species (ROS). In addition, target prediction and molecular docking analysis suggested that 2OBJ and 2WD9 could serve as putative molecular targets. In a three-dimensional tumor spheroid model, 2R effectively penetrated the spheroids and induced robust cell death in a dose-dependent manner. Collectively, these findings indicate that verbenone-selenophene derivative 2R represents a promising lead for further development as a novel anticancer candidate.